10 completed. 10 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 10 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow RNA analysis: new trials by email Literature Review of RNA analysis trials Research Report on RNA analysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma brentuximab vedotin, doxorubicin hydrochloride, vinblastine - Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma | Phase 2 | Completed | Northwestern University | 49 | 2011-11-01 | 2026-05-22 |
| Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cell Transplantation bortezomib, rituximab, laboratory biomarker analysis - Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma | Phase 2 | Completed | City of Hope Medical Center | 23 | 2011-10-03 | 2023-07-27 |
| Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma prednisone, cyclophosphamide, etoposide - Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma | Phase 2 | Completed | University of Nebraska | 34 | 2011-07-06 | 2023-09-22 |
| Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy Hsp90 inhibitor STA-9090, laboratory biomarker analysis, polymerase chain reaction - Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer | Phase 2 | Completed | Barbara Ann Karmanos Cancer Institute | 18 | 2011-01-01 | 2018-09-18 |
| Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer letrozole, panobinostat, RNA analysis - Breast Cancer | Phase 1 / Phase 2 | Completed | Alliance for Clinical Trials in Oncology | 28 | 2010-09-01 | 2017-06-27 |
| Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer bevacizumab, cetuximab, fluorouracil - Colorectal Cancer | Phase 2 / Phase 3 | Completed | Medical Research Council | 3240 | 2009-07-01 | 2013-12-19 |
| Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer imiquimod, Abraxane, laboratory biomarker analysis - Male Breast Cancer, Recurrent Breast Cancer | Phase 2 | Completed | University of Washington | 15 | 2008-12-01 | 2018-01-02 |
| Decitabine in Treating Patients With Previously Untreated Acute Myeloid Leukemia decitabine, laboratory biomarker analysis, pharmacological study - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q) | Phase 2 | Completed | National Cancer Institute (NCI) | 55 | 2007-05-01 | 2016-06-27 |
| Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer sorafenib tosylate, microarray analysis, immunohistochemistry staining method - Adenocarcinoma of the Prostate, Stage II Prostate Cancer | Phase 2 | Completed | University of Washington | 5 | 2006-12-01 | 2017-11-22 |
| Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors capecitabine, cisplatin, streptozocin - Gastrointestinal Carcinoid Tumor, Islet Cell Tumor | Phase 2 | Completed | Cambridge University Hospitals NHS Foundation Trust | 84 | 2005-08-01 | 2013-08-07 |
Breast Neoplasms (2) · Breast Neoplasms, Male (2) · Prostatic Neoplasms (2) · Adenoma, Islet Cell (1) · Carcinoma, Islet Cell (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Congenital Abnormalities (1) · Gastrinoma (1) · Glucagonoma (1) · Hodgkin Disease (1) · Immunoblastic Lymphadenopathy (1) · Insulinoma (1) · Lymphoma, Large-Cell, Anaplastic (1) · Lymphoma, Mantle-Cell (1)
University of Washington (2) · Alliance for Clinical Trials in Oncology (1) · Barbara Ann Karmanos Cancer Institute (1) · Cambridge University Hospitals NHS Foundation Trust (1) · City of Hope Medical Center (1) · Medical Research Council (1) · National Cancer Institute (NCI) (1) · Northwestern University (1) · University of Nebraska (1)
United States (8) · United Kingdom (2)
Elisabeth Heath (1) · Evan Yu (1) · Julie M Vose (1) · Leo Gordon, MD (1) · Lupe Salazar (1) · Matthew Mei (1) · Pippa Corrie, PhD, FRCP (1) · Tim Meyer, MD, BSc, MRCP, PhD (1) · Timothy Maughan, MD (1) · William Blum (1) · Winston Tan, MD, FACP (1)
PMID 20368434, PMID 26774555, PMID 28114604, PMID 29954415, PMID 30179569
N01CM62207 (1), P30CA036727 (1), R01CA138521 (1)